A.64 EPC Rights conferred by a European patent

(1)

A European patent shall, subject to the provisions of paragraph 2, confer on its proprietor from the date on which the mention of its grant is published in the European Patent Bulletin, in each Contracting State in respect of which it is granted, the same rights as would be conferred by a national patent granted in that State.

(2)

If the subject-matter of the European patent is a process, the protection conferred by the patent shall extend to the products directly obtained by such process.

(3)

Any infringement of a European patent shall be dealt with by national law.

[ Art. 2 67 68 97 ]

See decisions of the Enlarged Board of Appeal G 2/88, G 1/98 (Annex I).

Source: http://www.epo.org/law-practice/legal-texts/html/epc/2016/e/ar64.html

Date retrieved: 17 May 2021

44 references found.

Click X to load a reference inside the current page, click on the title to open in a new page.

EPC Articles

X Chapter III Effects of the European patent and the European patent application

X A.2 EPC European patent

X A.67 EPC Rights conferred by a European patent application after publication

X A.68 EPC Effect of revocation or limitation of the European patent

X A.97 EPC Grant or refusal

X A.105a EPC Article 105a Request for limitation or revocation

EPO Guidelines - D Opposition and Limitation/Revocation Procedures

X GL D X 3 Decision on request for revocation

EPO Guidelines - F The European Patent Application

X GL F IV 3.1 Categories

X GL F IV 4.12 Product-by-process claim

X GL F IV 4.16 Use claims

EPO Guidelines - G Patentability

X GL G II 5.4.1 Plant varieties

Offical Journal of the EPO

X OJ EPO 2020, A119 - Opinion of the Enlarged Board of Appeal dated 14 May 2020 - G 3/19

X OJ EPO 2020, A104 - Interlocutory Decision of Technical Board of Appeal 3.3.01 dated 7 February 2019 - T 318/14

X OJ EPO SE 6/2017, p122 - G. Institutional matters

X OJ EPO SE 4/2017, p2 - BOARD OF APPEAL AND ENLARGED BOARD OF APPEAL CASE LAW 2015/2016

X OJ EPO 2013, 42 - Decision of Technical Board of Appeal 3.3.04 dated 31 May 2012 T 1242/06 3.3.04

X OJ EPO 2012, 516 - Decision of the Legal Board of Appeal dated 25 November 2011 J 4/11 3.1.01

X OJ EPO 2011, 542 - Decision of Technical Board of Appeal 3.3.02 dated 27 October 2010 T 1635/09

X OJ EPO 2011, 336 - Decision of the Enlarged Board of Appeal dated 27 September 2010 G 1/09

X OJ EPO 2010, 100 - Decision of the Legal Board of Appeal dated 27 May 2009 J 2/08 3.1.01

Case Law Book: I Patentability

X CLR I C 8.1.3.B Different treatment of use and process claims

Case Law Book: II Conditions to be met by an Application

X CLR II A 1.1 Purpose of claims under Article 84 EPC

X CLR II A 7.1 Introduction

X CLR II E 2.6.1.C From product claim to a claim directed to using a product for producing another product – Article 64(2) EPC

X CLR II E 2.6.5 From use claim to process claim, and vice versa

X CLR II E 2.6.7 From Swiss-type claim to purpose related product claim under Article 54(5) EPC

X CLR II F 3.5.6 Pendency in case of deemed withdrawal of earlier application and request for re-establishment

Case Law Book: IV Divisional Applications

X CLR IV C 1 Legal character of opposition proceedings and applicable principles

Case Law of the Enlarged Board

X G 0002/88 (Friction reducing additive) of 11.12.1989

X G 0001/98 (Transgenic plant/NOVARTIS II) of 20.12.1999

X G 0002/12 () of 25.3.2015

X G 0002/13 () of 25.3.2015

X G 0003/14 () of 24.3.2015

General Case Law

X J 0024/10 () of 15.4.2011

X T 1242/06 (Tomatoes II/STATE OF ISRAEL) of 31.5.2012

X T 0547/08 () of 10.3.2011

X T 1349/08 (Hydrocarbon preparation/AGIP PETROLI) of 16.3.2010

X T 1798/08 () of 21.8.2012

X T 1635/09 (Zusammensetzung fÃ¼r EmpfÃ¤ngnisverhÃ¼tung/BAYER SCHERING PHARMA AG) of 27.10.2010

X T 1673/11 (Treatment of Pompe's disease/GENZYME) of 20.10.2015

X T 2563/11 (Doppelpatentierung) of 5.9.2017

X T 1849/12 () of 3.12.2012

X T 1954/12 (Recombinant vitamin K epoxide reductase/UNIVERSITY NORTH CAROLINA) of 27.10.2016

X T 0084/16 (PAR-1 activation/TUFTS) of 27.1.2017